✦ LIBER ✦

Timing of first-line cancer treatments – Early versus late – A systematic review of phase III randomized trials

✍ Scribed by A.R. Mhaskar; G. Quinn; S. Vadaparampil; B. Djulbegovic; C.K. Gwede; A. Kumar

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of Prostate Cancer With Interm

✍ Niraula, S.; Le, L. W.; Tannock, I. F. 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 160 KB

Sunitinib Plus Paclitaxel Versus Bevaciz

✍ Nicholas J. Robert; Mansoor N. Saleh; Devchand Paul; Daniele Generali; Laurent G 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 798 KB

669 A phase III randomized trial of bend

✍ G. von Minckwitz; I. Chemozemsky; R. Souchon; N. Stuart; J. Vermorken; K. Merkle 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 141 KB

S-1 plus cisplatin versus S-1 alone for

✍ Wasaburo Koizumi; Hiroyuki Narahara; Takuo Hara; Akinori Takagane; Toshikazu Aki 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 155 KB

Re: Treatment of Prostate Cancer with In

✍ Tombal, Bertrand 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Phase III Randomized Trial of Droloxifen

✍ A. Buzdar; D. Hayes; A. El-Khoudary; S. Yan; P. Lønning; M. Lichinitser; R. Gopa 📂 Article 📅 2002 🏛 Springer US 🌐 English ⚖ 130 KB